FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and deals with application of composition, which includes rotigotine in concentration, sufficient for providing flow of rotigotine, necessary for obtaining therapeutic effect, and, at least one chloride salt in concentration from 1 to 140 mmol/l, where said composition has pH from 4 to 6.5, for charging device for ionophoresis for treatment of Parkinson disease.
EFFECT: group of inventions provides flow of rotigotine through stratum comeum of humans, which is higher than flow, earlier obtained with application of conventional systems of passive diffusion.
9 cl, 3 ex
| Title |
Year |
Author |
Number |
| IONTOPHORETIC ROTIGOTINE DELIVERY IN TREATMENT FOR PARKINSON'S DISEASE |
2003 |
- Vol'Ff Khans-Mikhaehl'
- Bauvstra Jokhanna Alt'E
- Li Gaj Ling
- Njugrokho Akhmad Kharis
|
RU2339372C2 |
| PERCUTANEOUS THERAPEUTIC SYSTEM FOR TREATMENT OF PARKINSON'S DISEASE INDUCING HIGH ROTIGOTIN PLASMA LEVEL |
2002 |
- Lauterbakh Tomas
- Shakht Ditrikh Vil'Khel'M
- Vol'F Khans-Mikaehl'
- Mjuller Val'Ter
|
RU2272625C2 |
| ORAL QUICKLY DISSOLVING COMPOSITIONS OF DOPAMINE AGONISTS |
1996 |
- Dzhonson Ehdvard Stjuart
- Klark Ehntoni
- Grin Richard Dehvid
|
RU2189226C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING PARKINSON'S DISEASE |
2009 |
- Lamensdorf Itshak
- Sela Joram
|
RU2540470C9 |
| IMPROVED TRANSCUTANEOUS THERAPY SYSTEM FOR TREATING PARKINSON DISEASE CASES |
2002 |
- Lauterbakh Tomas
- Shakht Ditrikh Vil'Khel'M
- Vol'F Khans-Mikaehl'
- Mjuller Val'Ter
|
RU2273477C2 |
| METHOD OF PRODUCING (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND INTERMEDIATE COMPOUNDS FOR ITS PRODUCTION |
2020 |
- Dzhukhl, Martin
- Yakobsen, Mikkel,Fog
- Kvaerno, Lisbet
|
RU2817700C2 |
| NEW CATECHOLAMINE-BASED PRODRUGS FOR USE IN TREATMENT OF PARKINSON'S DISEASE |
2018 |
- Jensen Klaus Gervig
- Kvaerno Lisbet
- Dzhukhl Martin
- Jorgensen Morten
|
RU2806075C2 |
| PREVENTIVE AND THERAPEUTIC AGENT FOR POSTERIOR EYE DISEASES |
2008 |
- Okamoto Kazuesi
- Sibagaki Keiiti
|
RU2470635C2 |
| APPLICATION OF BENZTROPINE TO ABORT PROGRESSION OF AXIAL MYOPIA IN HUMANS |
2017 |
|
RU2793238C2 |
| VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS |
2009 |
- Lagard Anuk
- Flosh Stefan
- Bertehm T'Erri
|
RU2528892C2 |
